Academic medical centers and financial conflicts of interest.

摘要

Exposure does not necessarily prompt antidotes but notable progress is being made in managing and reducing individual conflicts of interest. Although some can still claim that "modest gifts are harmless," or that "research integrity cannot be undermined by the lure of profits," federal regulations and AMC procedures are becoming far more rigorous. The guidelines on pharmaceutical company-clinician relationships issued by the American Medical Association5 and also by the Pharmaceutical Research and Manufacturers of America6 have been superseded by stricter, if not entirely satisfactory, guidance from the Office of Inspector General, US Department of Health and Human Services.